Natasha S. Hochberg, MD, MPH

Natasha S. Hochberg, MD, MPH, is an infectious disease physician at Boston Medical Center (BMC) and Associate Professor of Medicine in the Section of Infectious Diseases at Boston University Chobanian & Avedisian School of Medicine. She sees travelers and patients with tropical diseases in the Travel Clinic, with a particular focus on Chagas disease and other parasitic infections.

Dr. Hochberg’s primary position is Director of Global Health Translational Medicine at Novartis Institutes for BioMedical Research. Previously, she was an Epidemic Intelligence Service (EIS) officer in the Division of Parasitic Diseases at the Centers for Disease Control & Prevention (CDC) and worked internationally on projects related to malaria, visceral leishmaniasis, guinea worm disease, and lymphatic filariasis. At BMC, she has also held the roles of Co-Director of the Travel Clinic and Director of Tropical Medicine; and she has served as Co-Site Director for GeoSentinel, an international surveillance system of diseases in travelers and migrants.

Dr. Hochberg’s research focuses on tropical diseases, particularly the impact of malnutrition and parasitic disease on tuberculosis (TB), tropical diseases in immigrant populations, and preventing diseases in international travelers. She was the principal investigator of the TB LION study (Learning the Impact Of Nutrition) in Pondicherry, India, which investigated the impact of malnutrition and parasitic infections on the immune response to tuberculosis and how this changes after providing a high-protein food package, multivitamin, and deworming. She was also site principal investigator of the US-Indo RePORT study in Pondicherry, India.

She is part of the American Society of Tropical Medicine and Hygiene, where she serves as President of the Clinical Group, and previously served as a member of the Scientific Program Committee; a clinical group councilor; and as the Chair for the Subcommittee on Pneumonia, Respiratory Infections, and TB.